FNY Partners Fund’s Pfizer PFE Stock Holding History

FNY Partners Fund’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-105	Closed	-$3K	–	565
2017 Q3	$3K	Buy	+105	New	+$3.38K	﹤0.01%	483

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

FNY Partners Fund's PFE Position: Q2 2017 in Review

FNY Partners Fund sold out of Pfizer (PFE) in Q2 2017, closing a stake of 527 shares — an estimated $17K sold.

FNY Partners Fund first reported a position in PFE in Q1 2017 and held it in 1 quarter. The position peaked at $17K in Q1 2017. 2,050 funds tracked by Wall St. Rank hold PFE as of Q2 2017.

FNY Partners Fund reported no remaining Pfizer position as of Q2 2017 after selling out during the quarter.
FNY Partners Fund sold 527 Pfizer shares in Q2 2017, an estimated $17K.
FNY Partners Fund first reported a position in Pfizer in Q1 2017 and held it in 1 quarter.
FNY Partners Fund's Pfizer position peaked at $17K in Q1 2017.
2,050 funds tracked by Wall St. Rank held Pfizer as of Q2 2017.

Based on FNY Partners Fund's 13F filing for Q2 2017, filed 10 Aug 2017.